WIN 2019 Program

Please see below for details of both Sunday and Monday's program:

 

MONDAY 24th JUNE, 2019

SESSION 3: DISRUPTIVE CONCEPTS AND INNOVATION ACROSS THE GLOBE 
Chairs:
Razelle Kurzrock, University of California, San Diego (UCSD), USA
Vivek Subbiah, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

 08:30

Keynote Lecture
A Precision Medicine Approach to Therapeutic Resistance using Keap1 Somatic Mutations to Target Patients to Correct Protein-Protein Interaction Disrupted by this Mutation

Gerald Batist, MD

McGill University - Segal Cancer Centre, Canada

08:50

Direct Targeting of STAT3 Alone and in Combination with Immune Checkpoint Inhibitors to Treat Solid Tumors

David J. Tweardy, MD

University of Texas MD Anderson Cancer Center, Houston, Texas, USA

09:10 CDK4/6 Inhibitors in Breast Cancer; today’s real and future dream

Hikmat Abdelrazeq, MD

King Hussein Cancer Center, Jordan

09:30

RET inhibition in RET aberrant cancers

Vivek Subbiah, MD

University of Texas MD Anderson Cancer Center, Houston, Texas, USA

09:50

The Value of Personalized Medicines for Healthcare Systems in Europe – Considering enablers to the adoption of personalized medicines in Europe

Anthony Barron

European Biopharmaceutical Enterprises (EBE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium

10:10

Panel Discussion 

Moderators:
Session's Chairs

10:30

Coffee Break, Networking

SESSION 4: DEPLOYMENT OF PRECISION ONCOLOGY  
Chairs:
Apostolia-Maria Tsimberidou, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Nicolas Girard, Institut Curie, Paris, France

 11:00

Keynote Lecture
Development and Application of Precision Oncology in China

Xin Hu, MD., PhD

Fudan University Shanghai Cancer Center, China

11:20

Rapidly changing landscape of precision medicine in Japan

Sadakatsu Ikeda, MD

Tokyo Medical and Dental University, Japan

11:40

National Cancer Grid of India - earthshots over moonshots

CS Pramesh, MS, FRCS, PGDCT

TATA Memorial Hospital, India

12:00

Data Sharing and System Interoperability: The Osiris French Program

Pierre Saintigny, MD., PhD

Centre Léon Bérard, France

12:20

Innovative Algorithms and IT Platform to Support Clinical Trials

Eitan Rubin, PhD

Ben Gurion University of the Negev, Israel

12:40

Panel Discussion

Moderators:
Session's Chair

13:00

Lunch, Poster Viewing and Networking

SESSION 5: NEW CONCEPTS AND THERAPEUTICS APPROACHES IN PRECISION ONCOLOGY 
Chairs:
Xin Hu, Fudan University Shanghai Cancer Center, China
Ulrik Lassen, Rigshospitalet, Copenhagen, Denmark

14:00 

Keynote Lecture
Decision Support for Precision Oncology: Evolving from Monotherapy to Genomically Informed Combinations

Funda Meric-Bernstam, MD

University of Texas MD Anderson Cancer Center, Houston, Texas, USA

14:20

The Use of Platform Studies for the Evaluation of Innovative Combinations in Solid Tumors and Haematologic Malignancies

Elizabeth Pease

AstraZeneca, UK

14:40

Oncobox, RNA Sequencing and Molecular Pathway Analysis-Based Second Opinion System for Prescription of Target Drugs to Advanced Cancer Patients: Concept, Design and Results of Clinical Trials

Anton Buzdin, PhD, DSc

Sechenov Moscow First Medical University, Russia

15:20

Matched Tumor/Normal Expression Profiling from Small FFPE Samples

Debrah Thompson, PhD

HTG Molecular Diagnostics, Inc., USA

15:40

Integration of DNA and RNA Investigations in Clinical Trials: a Laboratory Challenge

Brandon Young

Bowden WIN Precision Oncology Laboratory, Murrieta,  USA

16:00

Coffee Break, networking

SESSION 6: BEST POSTERS' AWARD

 16:30

Best 2 Posters Presentations and Awards

17:10

Conclusions

Richard L. Schilsky MD., FACP, FASCO, FSCT

Chairman WIN Consortium, ASCO®, USA

Josep Tabernero MD, PhD

Vice-Chairman WIN Consortium, Vall d’Hebron Institute of Oncology (VHIO), Spain. President ESMO, Switzerland

 

WIN 2020 Symposium
c/o MCI UK Ltd
Durford Mill
Petersfield
GU31 5AZ

Tel: +44 (0) 1730 715223
General enquiries: win2020@mci-group.com
Sponsorship enquiries: win2020@mci-group.com
Abstract enquiries: win2020abstracts@mci-group.com
Registration enquiries: win.reghot@mci-group.com

View Our Privacy Policy Here